Our technology
Allera collaborating with H. Lee Moffitt Cancer Center researchersSeptember 10, 2008 Allera collaborating with H. Lee Moffitt Cancer Center researchers Tampa, FL (September 2008) – Allera Health Products has entered into research collaboration with Dr. Esteban Celis, a professor in the Immunology and Immunotherapy Program at the H. Lee Moffitt Cancer Center & Research Institute.
Prior to joining Moffitt, Dr. Celis received his M.D. and Ph.D. from the National University of Mexico. He has worked in biotechnology companies and as a professor at the Mayo Clinic and is recognized for his contributions to the understanding of the basic biology of T cells against cancer. He has written more than 100 research articles and is the associate editor of Cancer Research. Celis is the former associate editor and the current section editor of The Journal of Immunology. He is on the Board of Scientific Counselors at the National Cancer Institute; a member of the American Association of Immunologists and the Clinical Immunology Society and the American Association for the Advancement of Science.
“ We are extremely pleased to be able to work with Dr. Celis to discover the precise mechanism by which Proligna pinecone extract enhances the immune response”, says Dr. Tufaro, President and CEO of Allera. “Dr. Celis has already generated some intriguing early results, and we are gratified that he has chosen to continue this important work for us”.
In 2001, the National Cancer Institute awarded Moffitt the status of a Comprehensive Cancer Center in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in the U.S. News & World Report as one of the top cancer hospitals in America. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.
